VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+2.93%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-5.1%)
Cap. Flow
-$9.35M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| 1 |
Dow Inc
DOW
|
$1.16M |
| 2 |
Hershey
HSY
|
$1.04M |
| 3 |
Copart
CPRT
|
$1.03M |
| 4 |
lululemon athletica
LULU
|
$1.02M |
| 5 |
Progressive
PGR
|
$999K |
Top Sells
| 1 |
Lennar Class A
LEN
|
$952K |
| 2 |
TJX Companies
TJX
|
$909K |
| 3 |
Ameriprise Financial
AMP
|
$902K |
| 4 |
Abbott
ABT
|
$892K |
| 5 |
Home Depot
HD
|
$885K |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Geron
GERN
$938M
| $93.4K | 0.05% |
43,051
-16,553
| -28% | -$35.9K |
|
352
Xenon Pharmaceuticals
XENE
$3.03B
| $93.4K | 0.05% |
2,610
-1,006
| -28% | -$36K |
|
353
Nuvation Bio
NUVB
$1.01B
| $93.3K | 0.05% |
56,210
-21,606
| -28% | -$35.9K |
|
354
Seres Therapeutics
MCRB
$171M
| $92.7K | 0.05% |
16,343
-6,285
| -28% | -$35.6K |
|
355
Viridian Therapeutics
VRDN
$1.56B
| $92.2K | 0.05% |
3,623
-1,394
| -28% | -$35.5K |
|
|
CERE
356
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $91.7K | 0.05% |
3,760
-1,451
| -28% | -$35.4K |
|
357
Iovance Biotherapeutics
IOVA
$792M
| $91.7K | 0.05% |
15,009
-5,773
| -28% | -$35.3K |
|
358
CRISPR Therapeutics
CRSP
$4.79B
| $91.2K | 0.05% |
2,017
-774
| -28% | -$35K |
|
|
IMAB
359
I-MAB
IMAB
$357M
| $91.2K | 0.05% |
26,347
-10,129
| -28% | -$35K |
|
360
Avidity Biosciences
RNA
$6.08B
| $91K | 0.05% |
5,931
-2,284
| -28% | -$35.1K |
|
361
Vir Biotechnology
VIR
$695M
| $90.9K | 0.05% |
3,905
-1,503
| -28% | -$35K |
|
362
Celldex Therapeutics
CLDX
$1.46B
| $90.4K | 0.05% |
2,513
-967
| -28% | -$34.8K |
|
363
Revolution Medicines
RVMD
$7.39B
| $90.3K | 0.05% |
4,169
-1,602
| -28% | -$34.7K |
|
364
Cogent Biosciences
COGT
$1.68B
| $90.3K | 0.05% |
8,367
-3,209
| -28% | -$34.6K |
|
|
KRTX
365
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $90.3K | 0.05% |
497
-188
| -27% | -$34.1K |
|
366
Biohaven
BHVN
$1.68B
| $87.9K | 0.05% |
6,438
-2,478
| -28% | -$33.8K |
|
367
Akero Therapeutics
AKRO
$3.63B
| $87.6K | 0.05% |
2,289
-875
| -28% | -$33.5K |
|
368
Zentalis Pharmaceuticals
ZNTL
$124M
| $87.1K | 0.05% |
5,065
-1,945
| -28% | -$33.5K |
|
369
Syndax Pharmaceuticals
SNDX
$1.39B
| $87K | 0.05% |
4,120
-1,581
| -28% | -$33.4K |
|
370
Cullinan Oncology
CGEM
$442M
| $86.8K | 0.05% |
8,483
-3,268
| -28% | -$33.4K |
|
371
uniQure
QURE
$933M
| $86.7K | 0.05% |
4,306
-1,649
| -28% | -$33.2K |
|
|
MRTX
372
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $86.2K | 0.05% |
2,318
-885
| -28% | -$32.9K |
|
373
Keros Therapeutics
KROS
$638M
| $86.1K | 0.05% |
2,017
-771
| -28% | -$32.9K |
|
374
Kodiak Sciences
KOD
$455M
| $86.1K | 0.05% |
13,880
-5,334
| -28% | -$33.1K |
|
375
Cytokinetics
CYTK
$5.94B
| $86K | 0.05% |
2,445
-938
| -28% | -$33K |
|